| Record Information |
|---|
| Version | 2.0 |
|---|
| Created at | 2022-04-28 08:04:49 UTC |
|---|
| Updated at | 2022-04-28 08:04:49 UTC |
|---|
| NP-MRD ID | NP0063722 |
|---|
| Secondary Accession Numbers | None |
|---|
| Natural Product Identification |
|---|
| Common Name | Arglabin |
|---|
| Description | Arglabin belongs to the class of organic compounds known as guaianolides and derivatives. These are diterpene lactones with a structure characterized by the presence of a gamma-lactone fused to a guaiane, forming 3,6,9-trimethyl-azuleno[4,5-b]furan-2-one or a derivative. Arglabin is found in Artemisia glabella, Artemisia myriantha, Pentzia eenii and Pentzia spp.. Arglabin was first documented in 2020 (PMID: 33247707). Based on a literature review a significant number of articles have been published on arglabin (PMID: 35289014) (PMID: 34655016) (PMID: 34634203) (PMID: 34352920) (PMID: 33760142) (PMID: 33410214). |
|---|
| Structure | CC1=CC[C@]23O[C@@]2(C)CC[C@@H]2[C@H](OC(=O)C2=C)[C@@H]13 InChI=1S/C15H18O3/c1-8-4-7-15-11(8)12-10(9(2)13(16)17-12)5-6-14(15,3)18-15/h4,10-12H,2,5-7H2,1,3H3/t10-,11+,12-,14-,15+/m0/s1 |
|---|
| Synonyms | | Value | Source |
|---|
| (+)-Arglabin | ChEBI | | 1beta,10beta-Epoxyguaia-3,11(13)-dien-12,6alpha-olide | ChEBI | | 1b,10b-Epoxyguaia-3,11(13)-dien-12,6a-olide | Generator | | 1Β,10β-epoxyguaia-3,11(13)-dien-12,6α-olide | Generator |
|
|---|
| Chemical Formula | C15H18O3 |
|---|
| Average Mass | 246.3060 Da |
|---|
| Monoisotopic Mass | 246.12559 Da |
|---|
| IUPAC Name | (1R,3S,6S,10S,11R)-3,12-dimethyl-7-methylidene-2,9-dioxatetracyclo[9.3.0.0^{1,3}.0^{6,10}]tetradec-12-en-8-one |
|---|
| Traditional Name | (1R,3S,6S,10S,11R)-3,12-dimethyl-7-methylidene-2,9-dioxatetracyclo[9.3.0.0^{1,3}.0^{6,10}]tetradec-12-en-8-one |
|---|
| CAS Registry Number | Not Available |
|---|
| SMILES | CC1=CC[C@]23O[C@@]2(C)CC[C@@H]2[C@H](OC(=O)C2=C)[C@@H]13 |
|---|
| InChI Identifier | InChI=1S/C15H18O3/c1-8-4-7-15-11(8)12-10(9(2)13(16)17-12)5-6-14(15,3)18-15/h4,10-12H,2,5-7H2,1,3H3/t10-,11+,12-,14-,15+/m0/s1 |
|---|
| InChI Key | UVJYAKBJSGRTHA-CUZKYEQNSA-N |
|---|
| Experimental Spectra |
|---|
|
| Not Available | | Predicted Spectra |
|---|
|
| | Spectrum Type | Description | Depositor ID | Depositor Organization | Depositor | Deposition Date | View |
|---|
| 1D NMR | 13C NMR Spectrum (1D, 25 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 100 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 252 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 50 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 200 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 75 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 300 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 101 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 400 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 126 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 500 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 151 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 600 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 176 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 700 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 201 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 800 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 226 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 900 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum |
| | Chemical Shift Submissions |
|---|
|
| Not Available | | Species |
|---|
| Species of Origin | |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as guaianolides and derivatives. These are diterpene lactones with a structure characterized by the presence of a gamma-lactone fused to a guaiane, forming 3,6,9-trimethyl-azuleno[4,5-b]furan-2-one or a derivative. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Lipids and lipid-like molecules |
|---|
| Class | Prenol lipids |
|---|
| Sub Class | Terpene lactones |
|---|
| Direct Parent | Guaianolides and derivatives |
|---|
| Alternative Parents | |
|---|
| Substituents | - Guaianolide-skeleton
- Sesquiterpenoid
- Gamma butyrolactone
- Alpha,beta-unsaturated carboxylic ester
- Enoate ester
- Tetrahydrofuran
- Carboxylic acid ester
- Lactone
- Carboxylic acid derivative
- Dialkyl ether
- Oxirane
- Ether
- Oxacycle
- Monocarboxylic acid or derivatives
- Organoheterocyclic compound
- Organic oxide
- Hydrocarbon derivative
- Carbonyl group
- Organooxygen compound
- Organic oxygen compound
- Aliphatic heteropolycyclic compound
|
|---|
| Molecular Framework | Aliphatic heteropolycyclic compounds |
|---|
| External Descriptors | |
|---|
| Physical Properties |
|---|
| State | Not Available |
|---|
| Experimental Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Predicted Properties | |
|---|
| General References | - Yang Y, Guo L, Wang J, Li W, Zhou X, Zhang C, Han C: Arglabin regulates microglia polarization to relieve neuroinflammation in Alzheimer's disease. J Biochem Mol Toxicol. 2022 Jun;36(6):e23045. doi: 10.1002/jbt.23045. Epub 2022 Mar 15. [PubMed:35289014 ]
- Manayi A, Nabavi SM, Khayatkashani M, Habtemariam S, Khayat Kashani HR: Arglabin could target inflammasome-induced ARDS and cytokine storm associated with COVID-19. Mol Biol Rep. 2021 Dec;48(12):8221-8225. doi: 10.1007/s11033-021-06827-7. Epub 2021 Oct 15. [PubMed:34655016 ]
- Li TZ, Yang XT, Wang JP, Geng CA, Ma YB, Su LH, Zhang XM, Chen JJ: Biomimetic Synthesis of Lavandiolides H, I, and K and Artematrolide F via Diels-Alder Reaction. Org Lett. 2021 Nov 5;23(21):8380-8384. doi: 10.1021/acs.orglett.1c03120. Epub 2021 Oct 11. [PubMed:34634203 ]
- Erdenetsogt U, Nadmid S, Paetz C, Dahse HM, Voigt K, Gotov C, Boland W, Dagvadorj E: New Guaianolide Sesquiterpene Lactones and Other Constituents from Pyrethrum pulchrum. Planta Med. 2022 Apr;88(5):380-388. doi: 10.1055/a-1554-2866. Epub 2021 Aug 5. [PubMed:34352920 ]
- Zeng N, Hongbo T, Xu Y, Wu M, Wu Y: [Retracted] Anticancer activity of caffeic acid nbutyl ester against A431 skin carcinoma cell line occurs via induction of apoptosis and inhibition of the mTOR/PI3K/AKT signaling pathway. Mol Med Rep. 2021 May;23(5). pii: 372. doi: 10.3892/mmr.2021.12011. Epub 2021 Mar 24. [PubMed:33760142 ]
- Adekenov SM, Shamilova ST, Khabarov IA: Analysis of arglabin and its derivatives using high-performance liquid chromatography. Phytochem Anal. 2021 Sep;32(5):780-784. doi: 10.1002/pca.3023. Epub 2021 Jan 6. [PubMed:33410214 ]
- Adekenov S, Zhumakayeva A, Perminov V, Bekmanov B, Rakhimov K: Neoadjuvant Therapy with Drug Arglabin for Breast Cancer with Expression of H-Ras Oncoproteins. Asian Pac J Cancer Prev. 2020 Nov 1;21(11):3441-3447. doi: 10.31557/APJCP.2020.21.11.3441. [PubMed:33247707 ]
- Su LH, Geng CA, Li TZ, Ma YB, Huang XY, Zhang XM, Chen JJ: Artatrovirenols A and B: Two Cagelike Sesquiterpenoids from Artemisia atrovirens. J Org Chem. 2020 Nov 6;85(21):13466-13471. doi: 10.1021/acs.joc.0c01491. Epub 2020 Oct 22. [PubMed:33089682 ]
- Ren Z, Yu P, Li D, Li Z, Liao Y, Wang Y, Zhou B, Wang L: Single-Cell Reconstruction of Progression Trajectory Reveals Intervention Principles in Pathological Cardiac Hypertrophy. Circulation. 2020 May 26;141(21):1704-1719. doi: 10.1161/CIRCULATIONAHA.119.043053. Epub 2020 Feb 26. [PubMed:32098504 ]
|
|---|